Signaling transduction network mediated by tumor suppressor/susceptibility genes in NPC

Current Genomics

Volumn 10, Issue 4, 2009, Pages 216-222

  Wu, Minghua ^a   Li, Xiayu ^a   Li, Xiaoling ^a   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA CATENIN; EPIDERMAL GROWTH FACTOR; EZRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; LACTOFERRIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; NASOPHARYNX CARCINOMA ASSOCIATED GENE 6 PROTEIN; NASOPHARYNX CARCINOMA ASSOCIATED GENE 7 PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN P16; PROTEIN P27; RAF PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RAS PROTEIN; REPRESSOR PROTEIN; RETINOBLASTOMA PROTEIN; SHORT PALATE LUNG AND NASAL EPITHELIUM CLONE 1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR BRD2; TRANSCRIPTION FACTOR BRD7; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER STAGING; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; FUNCTIONAL GENOMICS; HUMAN; METASTASIS; NASOPHARYNX CARCINOMA; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 68749110858     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920209788488481     Document Type: Review

References (68)

1. Busson, P.; Ooka, T.; Corbex, M. Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy. Med. Sci. (Paris), 2004, 20, 453-457.
2. Tao, Q.; Chan, A.T. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert. Rev. Mol. Med., 2007, 9, 1-24.
3. Feng, B.J.; Huang, W.; Shugart, Y.Y.; Lee, M.K.; Zhang, F.; Xia, J.C.; Wang, H.Y.; Huang, T.B.; Jian, S.W.; Huang, P.; Feng, Q.S.; Huang, L.X.; Yu, X.J.; Li, D.; Chen, L.Z.; Jia, W.H.; Fang, Y.; Huang, H.M.; Zhu, J.L.; Liu, X.M.; Zhao, Y.; Liu, W.Q.; Deng, M.Q.; Hu, W.H.; Wu, S.X.; Mo, H.Y.; Hong, M.F.; King, M.C.; Chen, Z.; Zeng, Y.X. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat. Genet., 2002, 31, 395-399.
4. Xiong, W.; Zeng, Z.Y.; Xia, J.H.; Xia, K.; Shen, S.R.; Li, X.L.; Hu, D.X.; Tan, C.; Xiang, J.J.; Zhou, J.; Deng, H.; Fan, S.Q.; Li, W,F.; Wang, R.; Zhou, M.; Zhu, S.G.; Lü, H.B.; Qian, J.; Zhang, B.C.; Wang, J.R.; Ma, J.; Xiao, B.Y.; Huang, H.; Zhang, Q.H.; Zhou, Y.H.; Luo, X.M.; Zhou, H.D.; Yang, Y.X.; Dai, H.P.; Feng, G.Y.; Pan, Q.; Wu, L.Q.; He, L.; Li, G.Y. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res., 2004, 64, 1972-1974.
5. Zhang, W.L.; Zhou, Y.H.; Xiao, L.; Fan, S.Q.; Zeng, Z.Y.; Li, X.L.; Wu, M.H.; Li, G.Y. Biomarkers of nasopharyngeal carcinoma. Prog. Biochem. Biophys., 2008, 35, 7-13.
6. Xiong, W.; Zeng, Z.Y.; Li, X.L.; Li, W.F.; Li, J.; He, L.; Li, G.Y. Single-nucleotide polymorphisms in NGX6 gene and their correlation with nasopharyngeal carcinoma. Sheng. Wu. Hua. Xue. Yu. Sheng. Wu. Wu. Li. Xue. Bao (Shanghai). 2002, 34, 512-515.
7. Xiong, W.; Zeng, Z.Y.; Shen, S.R.; Li, X.L.; Li, W.F.; Zhou, M.; Li, J.; He, L.; Feng, G.L.; Li, G.Y. Studies of single nucleotide polymorphisms in UBAP1 gene and their association with nasopharyngeal carcinoma. Prog. Biochem. Biophys., 2002, 29, 766-770.
8. Xiong, W.; Zeng, Z.Y.; Shen, S.R.; Li, X.L.; Li, W.F.; Zhou, M.; Li, J.; He, L.; Feng, G.L.; Li, G.Y. Studies of association between nasopharyngeal carcinoma and single-nucleotide polymorphisms in NOR1, a novel oxidored-nitro domain-containing protein gene. Prog. Biochem. Biophys., 2003, 30, 401-405.
9. Yu, Y.; Zhu, S.G.; Xiang, J.J.; Li, Z.H.; Zhang, B.C.; Cao, L.; Li, G.Y. Coding-region single nucleotide polymorphisms in BRD7 gene and nasopharyngeal carcinoma susceptiblity. Chin. J. Cancer, 2001, 28, 568-572.
10. Chou, J.; Lin, Y.C.; Kim, J.; You, L.; Xu, Z.; He, B.; Jablons, D. M. Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck, 2008, 30, 946-963.
11. Zhang, B.; Nie, X.; Xiao, B.; Xiang, J.; Shen, S.; Gong, J.; Zhou, M.; Zhu, S.; Zhou, J.; Qian, J.; Lu, H.; He, X.; Li, X.; Hu, G.; Li, G. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer, 2003, 38, 80-90.
12. Guyard-Dangremont, V.; Tenekjian, V.; Chauhan, V.; Walter, S.; Roy, P.; Rassart, E.; Milne, A.R. Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure. Protein Sci., 1999, 8, 2392-2398.
13. Mulero, J.J.; Boyle, B.J.; Bradley, S.; Bright, J.M.; Nelken, S.T.; Ho, T.T.; Mize, N.K.; Childs, J.D.; Ballinger, D.G.; Ford, J.E.; Rupp, F. Three new human members of the lipid transfer/lipopolysac-charide binding protein family (LT/LBP). Immunogenetics, 2002, 54, 293-300.
14. Zhou, H.D.; Li, X.L.; Li, G.Y. PLUNC family: novel class of innate immune protective molecules in upper airway. Prog. Biochem. Biophys., 2004, 31, 767-771.
15. Zhou, H.D.; Li, G.Y. Indentification of a Secretory Protein, SPLUNC1, Involved in the Naspharynheal Carcinoma Cell Apoptosis, Differentiation and Innate Immune Defence at the surface of Epithelium [D]. Changsha: Central South University; 2005.
16. Zhou, H.D.; Li, X.L.; Li, G.Y.; Zhou, M.; Liu, H.Y.; Yang, Y.X.; Deng, T.; Ma, J.; Sheng, S.R. Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus. Mol. Cell. Biochem., 2008, 9, 191-197.
17. Zhou, H.D.; Li, G.Y.; Yang, Y.X.; Li, X.L.; Sheng, S.R.; Zhang, W.L.; Zhao, J. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol. Immunol., 2006, 43, 1864-1871.
18. Blüthgen, N.; Legewie, S. Systems analysis of MAPK signal transduction. Essays Biochem., 2008, 45, 95-107.
19. Zhou, L.; Jiang, W.; Ren, C.; Yin, Z.; Feng, X.; Liu, W.; Tao, Q.; Yao, K. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia, 2005, 7, 809-815.
20. Lo, P.H.; Xie, D.; Chan, K.C.; Xu, F.P.; Kuzmin, I..; Lerman, M.I..; Law, S.; Chua, D.; Sham, J.; Lung, M.L. Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage. Cancer Lett., 2007, 257, 199-205.
21. Chow, L.S.; Lo, K.W.; Kwong, J.; To, K.F.; Tsang, K.S.; Lam, C.W.; Dammann, R.; Huang, D.P. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int. J. Cancer, 2004, 109, 839-847.
22. Man, C.; Rosa, J.; Lee, L.T.; Lee, V.H.; Chow, B.K.; Lo, K.W.; Doxsey, S.; Wu, Z.G.; Kwong, Y.L.; Jin, D.Y.; Cheung, A.L.; Tsao, S.W. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Oncogene, 2007, 26, 3069-3080.
23. Sherr, C.J. Cancer cell cycles. Science, 1996, 274, 1672-1677.
24. Sun, H.; Liu, J.; Zhang, J.; Shen, W.; Huang, H.; Xu, C.; Dai, H.; Wu, J.; Shi, Y. Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4. Biochem. Biophys. Res. Commun., 2007, 358, 435-441.
25. Peng, C.; Zhou, J.; Liu, H.Y.; Zhou, M.; Wang, L.L.; Zhang, Q.H.; Yang, Y.X.; Xiong, W.; Shen, S.R.; Li, X.L.; Li, G.Y. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. J. Cell. Biochem., 2006, 97, 882-892.
26. Yu, Y.; Zhu, S.G.; Zhang, B.C.; Li, Z.H.; Xiang, J.J.; Zhou, M.; Li, X.L.; Li, G.Y. Growth suppression of nasopharyngeal carcinoma cell through transfection of BRD7 gene. Chin. J. Cancer, 2001, 20, 569-574.
27. Liu, H.; Zhang, L.; Niu, Z.; Zhou, M.; Peng, C.; Li, X.; Deng, T.; Shi, L.; Tan, Y.; Li, G. Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells. BMC Cancer, 2008, 8, 253.
28. Liu, H.; Zhou, M.; Luo, X.; Zhang, L.; Niu, Z.; Peng, C.; Ma, J.; Peng, S.; Zhou, H.; Xiang, B.; Li, X.; Li, S.; He, J.; Li, X.; Li, G. Transcriptional regulation of BRD7 expression by Sp1 and c-Myc. BMC Mol. Biol., 2008, 9, 111.
29. Zhou, J.; Ma, J.; Zhang, B.C.; Li, X.L.; Shen, S.R.; Zhu, S.G.; Xiong, W.; Liu, H.Y.; Huang, H.; Zhou, M.; Li, G.Y. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. J. Cell. Physiol., 2004, 200, 89-98.
30. Peng, C.; Liu, H.Y.; Zhou, M.; Zhang, L.M.; Li, X.L.; Shen, S.R.; Li, G.Y. BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways. Mol. Cell. Biochem., 2007, 303, 141-149.
31. Rosalie, C.; Sears, R.C.; Nevins, J.R. Signaling networks that link cell proliferation and cell fate. J. Bio. Chem., 2002, 277, 11617-11620.
32. Zheng, N.; Fraenkel, E.; Pabo, C.O.; Pavletich, N.P. Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Gene. Dev., 1999, 13, 666-674.
33. Sun, J.; Nie, J.; Hao, B.; Li, L.; Xing, G.; Wang, Z.; Zhou, Y.; Sun, Q.; Li, G.; Zhang, L.; He, F. Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription- suppressing effect on cellular proliferation-associated genes. Cell. Signal, 2008, 20, 1151-1158.
34. Kim, S.; Lee, J.; Park, J.; Chung, J. BP75, bromodomain-containing M(r) 75,000 protein, binds dishevelled-1 and enhances Wnt signaling by inactivating glycogen synthase kinase-3 beta. Cancer Res., 2003, 63, 4792-4795.
35. Zhou, M.; Liu, H.; Xu, X.; Zhou, H.; Li, X.; Peng, C.; Shen, S.; Xiong, W.; Ma, J.; Zeng, Z.; Fang, S. Nie, X., Yang, Y., Zhou, J., Xiang, J.; Cao, L.; Peng, S.; Li, S.; Li, G. Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression. J. Cell. Biochem., 2006, 98, 920-930.
36. Hakomori, S. Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res., 1996, 56, 5309-5018.
37. Zhang, X.M.; Wang, X.Y.; Sheng, S.R.; Wang, J.R.; Li, J. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. World J. Gastroenterol., 2003, 9, 1729-1733.
38. Ma, J.; Zhou, J.; Fan, S.; Wang, L.; Li, X.; Yan, Q.; Zhou, M.; Liu, H.; Zhang, Q.; Zhou, H.; Gan, K.; Li, Z.; Peng, C.; Xiong, W.; Tan, C.; Shen, S.; Yang, J.; Li, J.; Li, G. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis, 2005, 26, 281-291.
39. Appellab, E.; Weber, I.T.; Blasi, F. Structure and function of epidermal growth factor-like regions in proteins. FEBS Lett., 1988, 231, 1-4.
40. Peng, S.P.; Li, X.L.; Wang, L.; Ou-Yang, J.; Ma, J.; Wang, L.L.; Liu, H.Y.; Zhou, M.; Tang, Y.L.; Li, W.S.; Luo, X.M.; Cao, L.; Tang, K.; Shen, S.R.; Li, G.Y. The role of NGX6 and its deletion mutants in the proliferation, adhesion and migration of nasopharyngeal carcinoma 5-8F cells. Oncology, 2006, 71, 273-281.
41. Wang, L.; Ma, J.; Li, J.; Li, X.; Zhang, Q.; Peng, S.; Peng, C.; Zhou, M.; Xiong, W.l Yang, J.; Zhou, J.; Fan, S.; Tan, C.; Yan, Q.; Shen, S.; Li, G. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J. Cell. Biochem., 2005, 95, 64-73.
42. Peng, S.; Fan, S.; Li, X.; Wang, L.; Liu, H.; Zhou, M.; Wang, L.; Shen, S.; Li, G. The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor. Cancer Sci., 2007, 98, 341-349.
43. Akisawa, N.; Nishimori, I.; Iwamura, T.; Onishi, S.; Hollingsworth, M.A. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem. Biophys. Res. Commun., 1999, 258, 395-400.
44. Xie, Y.; Bin, L.; Yang, J.; Li, Z.; Yu, Y.; Zhang, X.; Cao, L.; Li, G. Molecular cloning and characterization of NAG-7: a novel gene downregulated in human nasopharyngeal carcinoma. Chin. Med. J. (Engl). 2001, 114, 530-534.
45. Meng, Q.; Zhao, Z.; Yan, M.; Zhou, L.; Li, J.; Kitt, C.; Bin, G.; Fan, S. ERR-10: a new repressor in transcriptional signaling activation of estrogen receptor-alpha. FEBS Lett., 2004, 576, 190-200.
46. Fujita, T.; Kobayashi, Y.; Wada, O.; Tateishi, Y.; Kitada, L.; Yamamoto, Y.; Takashima, H.; Murayama, A.; Yano, T.; Baba, T.; Kato, S.; Kawabe, Y.; Yanagisawa, J. Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells. J. Biol. Chem., 2003, 278, 26704-26714.
47. Pinzone, J.J.; Stevenson, H.; Strobl, J.S.; Berg, P.E. Molecular and cellular determinants of estrogen receptor alpha expression. Mol. Cell. Biol., 2004, 24, 4605-4612.
48. Garcia, M.; Derocq, D.; Freiss, G.; Rochefort, H. Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc. Natl. Acad. Sci. USA 1992, 89, 11538-11542.
49. Platet, N.; Cunat, S.; Chalbos, D.; Rochefort, H.; Garcia, M. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol. Endocrinol., 2000, 14, 999-1009.
50. Tan, C.; Li, J.; Xie, Y.; Xiang, Q.; Wang, J.R.; Liang, S.P.; Li, G.Y. Preliminary Function Study of NAG7 Using Two-dimensional Electrophoresis and Mass Spectrometry. Sheng. Wu. Hua. Xue. Yu. Sheng. Wu. Wu. Li. Xue. Bao (Shanghai). 2001, 33, 373-378.
51. Tan, C.; Peng, C.; Huang, Y.C.; Zhang, Q.H.; Tang, K.; Li, X.L.; Li, G.Y. Effects of NPC-associated gene NAG7 on cell cycle and apoptosis in nasopharyngeal carcinoma cells. Chin. J. Cancer, 2002, 21, 449-455.
52. Tan, C.; Li, J.; Wang, J.; Xiang, Q.; Zhang, X.; Dong, L.; Shen, S.; Liang, S.; Li, G. Proteomic analysis of differential protein expression in human nasopharyngeal carcinoma cells induced by NAG7 transfection. Proteomics, 2002, 2, 306-312.
53. Huang, C. Molecular mechanism on NAG7 promote migration and invasion of nasopharyngeal carcinoma cells by estrogen receptor [D]. Changsha: Central South University; 2007.
54. Campbell, P.M.; Der, C.J. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin. Cancer Biol., 2004, 14, 105-114.
55. White, M.A.; Nicolette, C.; Minden, A.; Polverino, A.; Van, A.L.; Karin, M.; Wigler, M.H. Multiple Ras functions can contribute to mammalian cell transformation. Cell, 1995, 80, 533-541.
56. Shintani, Y.; Hollingsworth, M.A.; Wheelock, M.J.; Johnson, K.R. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res., 2006, 66, 11745-11753.
57. Khatlani, T.S.; Wislez, M.; Sun, M.; Srinivas, H.; Iwanaga, K.; Ma, L.; Hanna, A.E.; Liu, D.; Girard, L.; Kim, Y.H.; Pollack, J.R.; Minna, J.D.; Wistuba, I.I.; Kurie, J.M. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene, 2007, 26, 2658-2666.
58. Davidson, B.; Konstantinovsky, S.; Kleinberg, L.; Nguyen, M.T.; Bassarova, A.; Kvalheim, G.; Nesland, J. M.; Reich, R. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Gynecol. Oncol., 2006, 102, 453-461.
59. Sugioka, Y.; Watanabe, T.; Inagaki, Y.; Kushida, M.; Niioka, M.; Endo, H.; Higashiyama, R.; Okazaki, I. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line. Int. J. Cancer, 2004, 109, 867-874.
60. Murray, G.I.; Duncan, M.E.; O'Neil, P.; Melvin, W.T.; Fothergill, J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med., 1996, 2, 461-462.
61. Murray, G.I.; Duncan, M.E.; O'Neil, P.; McKay, J.A.; Melvin, W.T.; Fothergill, J.E. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol., 1998, 185, 256-261.
62. Song, R.X.; Zhang, Z.; Chen, Y.; Bao, Y.; Santen, R.J. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology, 2007, 148, 4091-4101.
63. van der Strate, B.W.; Beljaars, L.; Molema, G.; Harmsen, M.C.; Meijer, D.K. Antiviral activities of lactoferrin. Antiviral Res., 2001, 52, 225-239.
64. Iijima, H.; Tomizawa, Y.; Iwasaki, Y.; Sato, K.; Sunaga, N.; Dobashi, K.; Saito, R.; Nakajima, T.; Minna, J.D.; Mori, M. Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers. Int. J. Cancer., 2006, 118, 797-801.
65. Shaheduzzaman, S.; Vishwanath, A.; Furusato, B.; Cullen, J.; Chen, Y.; Bañez, L.; Nau, M.; Ravindranath, L.; Kim, K.H.; Mohammed, A.; Chen, Y.; Ehrich, M.; Srikantan, V.; Sesterhenn, I.A.; McLeod, D.G.; Vahey, M.; Petrovics,G.; Dobi, A.; Srivastava, S. Silencing of Lactotransferrin Expression by Methylation in Prostate Cancer Progression. Cancer Biol. Ther., 2007, 6.
66. Zeng, Z.; Zhou, Y.; Xiong, W.; Luo, X.; Zhang, W.; Li, X.; Fan, S.; Cao, L.; Tang, K.; Wu, M.; Li, G. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J. Cancer Res. Clin. Oncol., 2007, 33, 71-81.
67. Zhou, Y.; Zeng, Z.; Zhang, W.; Xiong, W.; Wu, M.; Tan, Y.; Yi, W.; Xiao, L. Li, X.; Huang, C.; Cao, L.; Tang, K.; Li, X.; Shen, S.; Li, G. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int. J. Cancer, 2008, 123, 2065-2072.
68. Yi, H.M.; Li, H.; Peng, D.; Zhang, H.J.; Wang, L.; Zhao, M.; Yao, K.T.; Ren, C.P. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncol. Res., 2006, 16, 261-272.